Health expenditure by type of service

Factors such as how care is organised and prioritised across providers, what the population needs are, and the various input costs, all affect how health spending is distributed across different services. Curative and rehabilitative care services comprise the greatest share – typically accounting for around 64% of all health spending across Asia-Pacific reporting countries (Figure 6.10). Medical goods (mostly retail pharmaceuticals) take up a further 15%, followed by a growing share on preventive care, which in 2019 averaged around 8% of health spending. Administration and overall governance of the health system, together with ancillary services and long-term care covered the remainder. Across OECD countries, long-term care and medical goods accounted for a higher share of health care spending as compared to Asia-Pacific reporting countries.

The structure of spending across the various types of care can vary considerably by country. More than three-quarters of health spending in Viet Nam, China, Cambodia and Malaysia can be accounted for by curative and rehabilitative care services. At the other end of the scale, Nepal saw curative and rehabilitative services account for less than half of all spending.

Spending on medical goods comprises the second largest category. As such, medical goods accounted for more than a fourth of all health spending in Nepal, India and the Philippines. Of note that spending on pharmaceuticals consumed in the hospital settings is not included -theoretically – in these figures.

Around one fourth of the total spending can be attributed to preventive care in Fiji, whereas preventive care accounts for only 3% of spending in Sri Lanka, and around this level in Australia, Japan and Korea.

When restricting the analysis to spending by government schemes and compulsory insurance schemes, curative and rehabilitative care services comprise the greatest share – typically accounting for 68% of all health spending across Asia-Pacific reporting countries (Figure 6.11). Preventive care takes up a further 10%. Administration and overall governance of the health system covered 16% of the remainder spending. Across OECD countries, long-term care and pharmaceuticals accounted for a higher share of government health care spending as compared to Asia-Pacific reporting countries. The low share of pharmaceuticals spending in government health spending at 4% flags the limitations of the benefit baskets in most Asia Pacific countries.

The structure of government and compulsory insurance spending across the various types of care can vary considerably by country. Around 90% of health spending in Sri Lanka can be attributed to curative and rehabilitative care services. At the other end of the scale, Lao PDR and Nepal saw curative and rehabilitative services account for half or less of all government spending. In Lao PDR, Cambodia and Nepal, the higher share of government spending was attributed to administration and other services.

Around 30% of government total spending is attributed to preventive care in Fiji, whereas preventive care accounts for 2% of government spending in Pakistan.

Metadata, Legal and Rights

This document, as well as any data and map included herein, are without prejudice to the status of or sovereignty over any territory, to the delimitation of international frontiers and boundaries and to the name of any territory, city or area. Extracts from publications may be subject to additional disclaimers, which are set out in the complete version of the publication, available at the link provided.

© OECD/WHO 2022

The use of this work, whether digital or print, is governed by the Terms and Conditions to be found at https://www.oecd.org/termsandconditions.